Cutler Group LP T2 Biosystems, Inc. Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	BUY	$0.36 - $0.57 $36 - $56	100 Added 4.2%	2,480 $1,000
Q4 2021 Jan 18, 2022	SELL	$0.46 - $0.94 $322 - $658	-700 Reduced 22.73%	2,380 $1,000
Q3 2021 Oct 26, 2021	BUY	$0.86 - $1.21 $258 - $363	300 Added 10.79%	3,080 $2,000
Q2 2021 Jul 19, 2021	BUY	$1.04 - $1.69 $2,891 - $4,698	2,780 New	2,780 $3,000
Q2 2019 Aug 09, 2019	SELL	$1.47 - $3.16 $147 - $316	-100 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$2.56 - $4.48 $1,280 - $2,240	-500 Reduced 83.33%	100 $0
Q3 2018 Nov 07, 2018	SELL	$5.36 - $7.83 $17,688 - $25,839	-3,300 Reduced 84.62%	600 $4,000
Q2 2018 Aug 10, 2018	BUY	$5.97 - $9.58 $14,925 - $23,950	2,500 Added 178.57%	3,900 $30,000
Q1 2018 May 11, 2018	BUY	$4.21 - $7.0 $5,894 - $9,800	1,400 New	1,400 $9,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.